• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发育与疾病中的基质金属蛋白酶

Matrix metalloproteinases in development and disease.

作者信息

Lemaître Vincent, D'Armiento Jeanine

机构信息

Department of Medicine, Division of Molecular Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.

出版信息

Birth Defects Res C Embryo Today. 2006 Mar;78(1):1-10. doi: 10.1002/bdrc.20065.

DOI:10.1002/bdrc.20065
PMID:16622845
Abstract

Matrix metalloproteinases (MMPs) are key modulators of many biological processes during pathophysiological events, such as skeletal formation, angiogenesis, cellular migration, inflammation, wound healing, coagulation, lung and cardiovascular diseases, arthritis, and cancer. Twenty-four members of the MMP family have been identified in humans, degrading many components of the extracellular matrix, cellular receptors, and cytokines. This review describes the molecular structure, activation and inhibition, and substrate specificity of MMPs, and their biological function in development and disease.

摘要

基质金属蛋白酶(MMPs)是病理生理过程中许多生物学过程的关键调节因子,如骨骼形成、血管生成、细胞迁移、炎症、伤口愈合、凝血、肺部和心血管疾病、关节炎以及癌症。在人类中已鉴定出24个MMP家族成员,它们可降解细胞外基质的许多成分、细胞受体和细胞因子。本文综述了MMPs的分子结构、激活与抑制、底物特异性及其在发育和疾病中的生物学功能。

相似文献

1
Matrix metalloproteinases in development and disease.发育与疾病中的基质金属蛋白酶
Birth Defects Res C Embryo Today. 2006 Mar;78(1):1-10. doi: 10.1002/bdrc.20065.
2
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.基质金属蛋白酶与金属蛋白酶组织抑制剂:结构、功能及生物化学
Circ Res. 2003 May 2;92(8):827-39. doi: 10.1161/01.RES.0000070112.80711.3D.
3
Matrix metalloproteinases and cellular motility in development and disease.基质金属蛋白酶与发育和疾病中的细胞运动性
Birth Defects Res C Embryo Today. 2006 Mar;78(1):69-79. doi: 10.1002/bdrc.20061.
4
What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?从小鼠模型中了解到的基质金属蛋白酶对心血管系统的影响有哪些?
Cardiovasc Res. 2006 Feb 15;69(3):585-94. doi: 10.1016/j.cardiores.2005.12.010. Epub 2006 Jan 19.
5
Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis.基质金属蛋白酶的生理作用:对肿瘤生长和转移的影响
Can J Physiol Pharmacol. 1999 Jul;77(7):465-80.
6
Matrix metalloproteinases in vascular physiology and disease.基质金属蛋白酶在血管生理与疾病中的作用
Vascular. 2012 Aug;20(4):210-6. doi: 10.1258/vasc.2011.201202. Epub 2012 Aug 15.
7
[Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].[细胞外基质——从基础研究到临床意义。特别考虑基质金属蛋白酶的综述]
Dtsch Med Wochenschr. 2004 Sep 17;129(38):1976-80. doi: 10.1055/s-2004-831836.
8
Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development.在胚胎发育过程中,巨噬细胞迁移在体内需要三种基质金属蛋白酶。
Mech Dev. 2008 Nov-Dec;125(11-12):1059-70. doi: 10.1016/j.mod.2008.07.005. Epub 2008 Jul 18.
9
Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.基质金属蛋白酶与生理和药理抑制剂复合物的晶体结构。
Biochimie. 2005 Mar-Apr;87(3-4):249-63. doi: 10.1016/j.biochi.2004.11.019.
10
Structure and function of matrix metalloproteinases and TIMPs.基质金属蛋白酶和金属蛋白酶组织抑制因子的结构与功能
Cardiovasc Res. 2006 Feb 15;69(3):562-73. doi: 10.1016/j.cardiores.2005.12.002. Epub 2006 Jan 5.

引用本文的文献

1
Targeting Matrix Metalloproteinases and Their Inhibitors in Melanoma.靶向黑色素瘤中的基质金属蛋白酶及其抑制剂
Int J Mol Sci. 2024 Dec 18;25(24):13558. doi: 10.3390/ijms252413558.
2
Significance of Fibrillin-1, Filamin A, MMP2 and SOX9 in Mitral Valve Pathology.纤维连接蛋白 1、细丝蛋白 A、MMP2 和 SOX9 在二尖瓣病变中的意义。
Int J Mol Sci. 2024 Aug 29;25(17):9410. doi: 10.3390/ijms25179410.
3
Comparison between a novel salivary marker and several clinical prognosticators in oral cavity cancer.一种新型唾液标志物与口腔癌中几种临床预后指标的比较。
Laryngoscope Investig Otolaryngol. 2023 Oct 12;8(6):1547-1556. doi: 10.1002/lio2.1166. eCollection 2023 Dec.
4
Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023).基质金属蛋白酶抑制剂在癌症治疗中的应用:更新综述(2013-2023)。
Molecules. 2023 Jul 21;28(14):5567. doi: 10.3390/molecules28145567.
5
Extracellular Matrix Remodeling in Vascular Disease: Defining Its Regulators and Pathological Influence.血管疾病中的细胞外基质重塑:定义其调控因子和病理影响。
Arterioscler Thromb Vasc Biol. 2023 Sep;43(9):1599-1616. doi: 10.1161/ATVBAHA.123.318237. Epub 2023 Jul 6.
6
Causal relationships between serum matrix metalloproteinases and estrogen receptor-negative breast cancer: a bidirectional mendelian randomization study.血清基质金属蛋白酶与雌激素受体阴性乳腺癌之间的因果关系:一项双向孟德尔随机化研究。
Sci Rep. 2023 May 15;13(1):7849. doi: 10.1038/s41598-023-34200-0.
7
Assessment of Atherosclerosis in Ischemic Stroke by means of Ultrasound of Extracranial/Intracranial Circulation and Serum, Urine, and Tissue Biomarkers.通过颅外/颅内循环超声以及血清、尿液和组织生物标志物评估缺血性卒中中的动脉粥样硬化
Curr Med Chem. 2023;30(10):1107-1121. doi: 10.2174/0929867329666220817123442.
8
Early Abnormal Placentation and Evidence of Vascular Endothelial Growth Factor System Dysregulation at the Feto-Maternal Interface After Periconceptional Alcohol Consumption.孕期酒精摄入后胎儿-母体界面早期胎盘异常植入及血管内皮生长因子系统失调的证据
Front Physiol. 2022 Feb 2;12:815760. doi: 10.3389/fphys.2021.815760. eCollection 2021.
9
Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.基质金属蛋白酶在癌症增殖、转移和药物靶向治疗中的作用。
Mol Biol Rep. 2021 Sep;48(9):6525-6538. doi: 10.1007/s11033-021-06635-z. Epub 2021 Aug 11.
10
PEDF, a pleiotropic WTC-LI biomarker: Machine learning biomarker identification and validation.PEDF,一种多效性 WTC-LI 生物标志物:机器学习生物标志物识别和验证。
PLoS Comput Biol. 2021 Jul 21;17(7):e1009144. doi: 10.1371/journal.pcbi.1009144. eCollection 2021 Jul.